肺血管平滑肌细胞钾通道分布不均--性及其病理生理调控

基本信息
批准号:39970332
项目类别:面上项目
资助金额:13.00
负责人:张珍祥
学科分类:
依托单位:华中科技大学
批准年份:1999
结题年份:2002
起止时间:2000-01-01 - 2002-12-31
项目状态: 已结题
项目参与者:熊盛道,赵建平,别毕华,方慧娟,刘辉国,倪望,甄国华,李耀军
关键词:
肺血管平滑肌细胞钾通道信号转导
结项摘要

Potassium channel plays an important role in the physiologic and pathophysiologic regulation of pulmonary vascular smooth muscle tension and in its hypoxic reaction. In this project, we used whole cell patch clamp, molecular biology and other research techniques and applied specific agonists and antagonists to investigate the heterogenic distribution of different subtypes of potassium channel in normal as well as chroni hypoxic pulmonary vascular branches and vascular cells. We also investigated the relevant intracellular signaling mechanisms. The effects of long term application of NO on the potassium was also observed. These researches are useful for understanding the pathogenesis of hypoxic pulmonary hypertensin and can provide theoretic bases for clinical therapy. The purpose of this project was, with the use of the technology of whole cell patch clamp and under the condition of hypoxia,to investigate: (1)the reactions of different potassium channels to hypoxia; (2)the regulatory effects of various intracellular secong messengers, such as cAMP, cGMP and PKC, on voltage-gated potassium channel; (3)the regulatory effects of endothelin-1 (ET-1) on voltage-gated potassium channel in pulmonary artery smooth muscle cells from hypoxia-exposed rats; (4)the ion mechanisms of long term application of NO precursor L-arginin for the treatment of chroni hypoxic pulmonary hypertension; (5)the effects of cro on hypoxic pulmonary hypertension and its mechanism; and (6)the effects of lev, the levogyrate cro, on pulmonary artery endothelial cells and smooth muscle cells on normal and hypoxic culture conditions.Results1.Many spindle shaped cells were obtained via acute enzyme seperation metnod and identified to be PASMC with ?-actin stain. The outward current recorded with whole cell patch clamp technique was proved to be potassium current while the K+ in the pipette was replaced with Cs+. The peak potassium current at +50 mV was 225.5 ( 3.6 pA/pF. The current of votalge-gated channel was stable and did not change with time. At the beginning of whole cell patch clamp, the tow are almost overlapped (Fig.1). 2. Chronic hypoxia decreased the resting membrane potential of PASMCs but had no effect on the resting membrane capacitance. Chronic hypoxia significantly inhibited the potassium ion current of voltage-gated potassium channelbut increased the potassium ion current of Ca2+-sensitive potassium channel (Fig2 and Fig3)..3. The voltage-gated K + current in PASMCs from normal rats was inhibitd by PKC and was reversed by inhibitor of PKC. GFX. On the other hand, PKC had no effect on the voltage-gated K+ currents in PASMCs from rats expsed to chronic hypoxia. These results suggest that PKC has different effect on voltage-gated K+ current under different conditions.(Fig4,5,6).4. The voltage-gated K+ current was significantly inhibited by cAMP in normal rats from 150.0 ( 9.4 pA/pF to 133.0 ( 1.8 pA/pF at +50 mV (n+6, P<0.05). This effect was reversed by H-89, cAMP+PKA inhibitor, and the voltage-gated K+ current measured was 102.8 ( 11.6 pA/pF and 103.8 ( 10.4 pA/pF,respectively (n=6, P>0.05). The voltage-gated K+ current in hypoxia group was not affected by cAMP and the current at 50 mV before and after the application of cAMP was 72.0 ( 2.3 pA/pF and 79.9 ( 3.3 pA/pF, respectively (n=6, P<0.05).(Fig7,8,9)5. cGMP exhibited inhibitory effects of voltage-gated potassium channel of PASMC from both normal and chronic hypoxic rats and this inhibition effect was reversed by H-8, an inghibitor of PKG, suggesting that the inhibitory effect of cGMP is dependent on the signaling pathway of protein kinase G Fig10,11,12,13)..6. Immunohistochemistry technique was used to investigate the expression of ET-1 and its receptor ETAand ETB along the axis of intra-pulmonary arteries. The results showed that along the axis of pulmonary arteries the expression of ET-1 increased gradually from the proximal end to the distal end. The positive staining was mainly located in the inner and medial membrain of pulmonary arteries. Chronic hypoxia led to an inc

钾通道在调控肺血管平滑肌生理、病理生理张力和氧反应笥中起重要作用。本课题拟用膜片钳技术、分子生物学技术及其它技术,结合特异的激动/拮抗剂,阐明不同亚型钾通道在正常/慢性缺氧肺血管段和血管平滑肌细胞分布不均一性,其细胞内调控机制以及长期应用NO对其影响,有助于进一步明确缺氧肺动脉高压发病机理,并为临床治疗提供理论基础。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

DOI:10.13692/ j.cnki.gywsy z yb.2016.03.002
发表时间:2016
2

涡轮叶片厚壁带肋通道流动与传热性能的预测和优化

涡轮叶片厚壁带肋通道流动与传热性能的预测和优化

DOI:10.7652/xjtuxb202112004
发表时间:2021
3

强震作用下铁路隧道横通道交叉结构抗震措施研究

强震作用下铁路隧道横通道交叉结构抗震措施研究

DOI:10.3969/j.issn.1000-0844.2020.01.182
发表时间:2020
4

静脉血栓形成时间推断的法医学研究进展

静脉血栓形成时间推断的法医学研究进展

DOI:10.12116/j.issn.1004-5619.2019.02.008
发表时间:2019
5

长链非编码RNA SFTA1P在肺腺癌中的表达及预后预测研究

长链非编码RNA SFTA1P在肺腺癌中的表达及预后预测研究

DOI:10.16016/j.1000-5404.202005271
发表时间:2020

相似国自然基金

1

老年及AD转基因动物中枢钾通道与相关神经病理生理的动态变化研究

批准号:30640096
批准年份:2006
负责人:王晓良
学科分类:H0912
资助金额:20.00
项目类别:专项基金项目
2

冠状动脉平滑肌钙激活钾通道活动的电生理特性及其调控

批准号:39370270
批准年份:1993
负责人:曾晓荣
学科分类:C1101
资助金额:5.00
项目类别:面上项目
3

肌细胞钾通道生理特性和棉酚低血钾机理研究

批准号:38671133
批准年份:1986
负责人:刘安西
学科分类:C09
资助金额:2.00
项目类别:面上项目
4

钾离子通道Kir2.1调控血管损伤后血管平滑肌细胞表型转换的作用及其机制

批准号:81370225
批准年份:2013
负责人:汤成春
学科分类:H0202
资助金额:65.00
项目类别:面上项目